Mechanism of acitretin-induced relaxations in isolated rat thoracic aorta preparations

dc.contributor.authorEfe, Oguzhan Ekin
dc.contributor.authorAydos, Tolga Resat
dc.contributor.authorAydingoz, Selda Emre
dc.contributor.orcID0000-0002-3243-7843en_US
dc.contributor.orcID0000-0001-7823-7620en_US
dc.contributor.pubmedID34411501en_US
dc.contributor.researcherIDW-7908-2019en_US
dc.contributor.researcherIDABA-4291-2020en_US
dc.date.accessioned2022-11-11T10:48:48Z
dc.date.available2022-11-11T10:48:48Z
dc.date.issued2022
dc.description.abstractAcitretin is a member of vitamin A-derived retinoids, and its effect on vascular smooth muscle had not yet been studied. The aim of this study is to investigate the effect of acitretin, a retinoid, on vascular smooth muscle contractility. Thoracic aorta preparations obtained from 34 male Sprague-Dawley rats (355 +/- 15 g) were studied in isolated organ baths containing Krebs-Henseleit solution. The relaxation responses were obtained with acitretin (10-12-10-4 M) in endotheliumpreserved and endothelium-denuded aorta preparations precontracted with submaximal concentration of phenylephrine (10-6 M). The role of retinoic acid receptors (RARs), nitric oxide, adenylyl, and guanylyl cyclase enzymes, and potassium channels in these relaxation responses were investigated. Acitretin produced concentration-dependent relaxations, which were independent of its solvent dimethylsulfoxide (DMSO), in endothelium-denuded phenylephrine-precontracted thoracic aorta preparations. While incubation with the RAR antagonist (AGN193109, 10-5 M) had no effect on these relaxations; nitric oxide synthase inhibitor (L-NG-Nitro arginine methyl ester (L-NAME), 10-4 M), adenylyl cyclase inhibitor (SQ2253, 10-5 M), guanylyl cyclase inhibitor (oxadiazolo [4,3-a] quinoxalin-1-one (ODQ), 10-6 M), and potassium channel blocker (tetraethylammonium (TEA), 10-2 M) significantly eliminated the relaxation responses induced by acitretin. Acitretin induces relaxation in rat isolated thoracic aorta preparations without endothelium, which may be mediated by nitric oxide, cyclic adenosine monophosphate, and cyclic guanosine monophosphate-dependent kinases and potassium channels.en_US
dc.identifier.endpage42en_US
dc.identifier.issn0008-4212en_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85122780928en_US
dc.identifier.startpage35en_US
dc.identifier.urihttps://tspace.library.utoronto.ca/bitstream/1807/108164/1/cjpp-2021-0206.pdf
dc.identifier.urihttp://hdl.handle.net/11727/8069
dc.identifier.volume100en_US
dc.identifier.wos000744530100006en_US
dc.language.isoengen_US
dc.relation.isversionof10.1139/cjpp-2021-0206en_US
dc.relation.journalCANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectretinoidsen_US
dc.subjectacitretinen_US
dc.subjectvascular smooth muscleen_US
dc.subjectaortaen_US
dc.subjectrelaxationen_US
dc.subjectdimethylsulfoxideen_US
dc.titleMechanism of acitretin-induced relaxations in isolated rat thoracic aorta preparationsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ds164.pdf
Size:
1.36 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: